- Home
- REX vs OPK Comparison
REX vs OPK Comparison
Compare REX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REX | OPK |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 921.2M |
| IPO Year | 1994 | 2011 |
Fundamental Metrics
Financial Performance| Metric | REX | OPK |
|---|---|---|
| Price | $39.48 | $1.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $25.00 | $2.03 |
| AVG Volume (30 Days) | 133.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $642,491,000.00 | $606,879,000.00 |
| Revenue This Year | $3.27 | N/A |
| Revenue Next Year | $17.11 | $4.76 |
| P/E Ratio | $33.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.02 | $1.11 |
| 52 Week High | $64.95 | $1.87 |
Technical Indicators
Market Signals| Indicator | REX | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 74.43 | 39.79 |
| Support Level | $38.88 | $1.12 |
| Resistance Level | $43.62 | $1.27 |
| Average True Range (ATR) | 1.21 | 0.05 |
| MACD | 0.40 | 0.00 |
| Stochastic Oscillator | 86.48 | 23.08 |
Price Performance
Historical ComparisonAbout REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.